Cargando…
IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 pat...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197178/ https://www.ncbi.nlm.nih.gov/pubmed/32366271 http://dx.doi.org/10.1186/s13075-020-02197-w |
_version_ | 1783528830680432640 |
---|---|
author | Peng, Linyi Zhang, Panpan Li, Jieqiong Liu, Zheng Lu, Hui Zhu, Liang Wang, Xiaorong Teng, Fei Li, Xuemei Guo, Huifang Fei, Yunyun Zhang, Wen Zhao, Yan Zeng, Xiaofeng Zhang, Fengchun |
author_facet | Peng, Linyi Zhang, Panpan Li, Jieqiong Liu, Zheng Lu, Hui Zhu, Liang Wang, Xiaorong Teng, Fei Li, Xuemei Guo, Huifang Fei, Yunyun Zhang, Wen Zhao, Yan Zeng, Xiaofeng Zhang, Fengchun |
author_sort | Peng, Linyi |
collection | PubMed |
description | BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 patients with IgG4-RD with a follow-up time of more than 6 months. The distribution of IgG4-related PAO/PA was classified into four types: type 1, thoracic aorta; type 2a, abdominal aorta; type 2b, abdominal aorta and iliac artery; type 2c, iliac artery; type 3, thoracic and abdominal aorta; and type 4, other arteries. Patient’s demographic data, clinical characteristics, laboratory parameters, and treatment efficacy were analyzed. RESULTS: Of 587 IgG4-RD patients, 89 (15.2%) had PAO/PA. The average age was 58.3 ± 11.1 years, with male predominance (85.4%). Vessels affected were as follows: abdominal aorta (83.1%), iliac artery (70.8%), thoracic aorta (13.5%), and other vessels (13.5%). The most prevalent distribution type of IgG4-related PAO/PA was type 2b, with 74 (83.1%) patients, followed by type 2a, type 2c, type 3, and type 1. Fifty-five (61.8%) PAO/PA patients had hydronephrosis, with renal insufficiency occurring in 43 (48.3%), and 31 (34.8%) PAO/PA patients had D-J stent drainage due to severe ureteral obstruction. After treatment with a glucocorticoid and immunosuppressants, 82% patients achieved remission with shrinking of the perivascular mass by more than 30%. CONCLUSIONS: IgG4-RD with PAO/PA was distinct from non-PAO/PA in demographic features, organ involvement distribution, inflammatory markers, and serum IgG4 and IgE. The most common affected vessel was the abdominal aorta, and most patients responded well with treatment. |
format | Online Article Text |
id | pubmed-7197178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71971782020-05-08 IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease Peng, Linyi Zhang, Panpan Li, Jieqiong Liu, Zheng Lu, Hui Zhu, Liang Wang, Xiaorong Teng, Fei Li, Xuemei Guo, Huifang Fei, Yunyun Zhang, Wen Zhao, Yan Zeng, Xiaofeng Zhang, Fengchun Arthritis Res Ther Research Article BACKGROUND: Large vessels could be involved in immunoglobulin (Ig)-G4-related disease (IgG4-RD). This study aimed to clarify the clinical features and evaluate the treatment efficacy for IgG4-RD with aortitis/periaortitis and periarteritis (PAO/PA). METHODS: This study prospectively enrolled 587 patients with IgG4-RD with a follow-up time of more than 6 months. The distribution of IgG4-related PAO/PA was classified into four types: type 1, thoracic aorta; type 2a, abdominal aorta; type 2b, abdominal aorta and iliac artery; type 2c, iliac artery; type 3, thoracic and abdominal aorta; and type 4, other arteries. Patient’s demographic data, clinical characteristics, laboratory parameters, and treatment efficacy were analyzed. RESULTS: Of 587 IgG4-RD patients, 89 (15.2%) had PAO/PA. The average age was 58.3 ± 11.1 years, with male predominance (85.4%). Vessels affected were as follows: abdominal aorta (83.1%), iliac artery (70.8%), thoracic aorta (13.5%), and other vessels (13.5%). The most prevalent distribution type of IgG4-related PAO/PA was type 2b, with 74 (83.1%) patients, followed by type 2a, type 2c, type 3, and type 1. Fifty-five (61.8%) PAO/PA patients had hydronephrosis, with renal insufficiency occurring in 43 (48.3%), and 31 (34.8%) PAO/PA patients had D-J stent drainage due to severe ureteral obstruction. After treatment with a glucocorticoid and immunosuppressants, 82% patients achieved remission with shrinking of the perivascular mass by more than 30%. CONCLUSIONS: IgG4-RD with PAO/PA was distinct from non-PAO/PA in demographic features, organ involvement distribution, inflammatory markers, and serum IgG4 and IgE. The most common affected vessel was the abdominal aorta, and most patients responded well with treatment. BioMed Central 2020-05-04 2020 /pmc/articles/PMC7197178/ /pubmed/32366271 http://dx.doi.org/10.1186/s13075-020-02197-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Peng, Linyi Zhang, Panpan Li, Jieqiong Liu, Zheng Lu, Hui Zhu, Liang Wang, Xiaorong Teng, Fei Li, Xuemei Guo, Huifang Fei, Yunyun Zhang, Wen Zhao, Yan Zeng, Xiaofeng Zhang, Fengchun IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title | IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title_full | IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title_fullStr | IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title_full_unstemmed | IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title_short | IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease |
title_sort | igg4-related aortitis/periaortitis and periarteritis: a distinct spectrum of igg4-related disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197178/ https://www.ncbi.nlm.nih.gov/pubmed/32366271 http://dx.doi.org/10.1186/s13075-020-02197-w |
work_keys_str_mv | AT penglinyi igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zhangpanpan igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT lijieqiong igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT liuzheng igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT luhui igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zhuliang igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT wangxiaorong igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT tengfei igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT lixuemei igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT guohuifang igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT feiyunyun igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zhangwen igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zhaoyan igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zengxiaofeng igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease AT zhangfengchun igg4relatedaortitisperiaortitisandperiarteritisadistinctspectrumofigg4relateddisease |